News - Merck KGaA, Immunologicals

Filter

Current filters:

Merck KGaAImmunologicals

Popular Filters

Merck’s Allergopharma to invest 40 million euros in production facility

Merck’s Allergopharma to invest 40 million euros in production facility

12-12-2013

Germany’s Merck KGaA has broken ground on a new production facility for its Allergopharma unit in Reinbek…

AllergopharmaFinancialImmunologicalsMerck KGaAPharmaceuticalProduction

Merck Serono sets up new platform for cancer therapies innovation

26-06-2013

Merck Serono, the biopharmaceutical division of Germany's Merck KGaA (MRK: DE) says it has created a…

BiotechnologyImmunologicalsMerck KGaAMerck SeronoOncologyPharmaceuticalResearch

Ablynx earns milestone from Merck Serono

13-12-2011

Belgium’s Ablynx (Euronext Brussels: ABLX) says it will earn a 1 million-euro ($1.3 million) from…

AblynxBiotechnologyFinancialImmunologicalsMerck KGaAMerck SeronoPharmaceuticalResearch

Merck KGaA has another stab at multiple sclerosis, gaining rights to Peptimmune PI-2301 program

19-09-2011

German drug major Merck KGaA (MRK: DE) is taking another look at the multiple sclerosis market, where…

BiotechnologyImmunologicalsLicensingMerck KGaANeurologicalPeptimmunePharmaceutical

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top